Stryker Corp (SYK) stock analysis
Healthcare · Medical Devices
Revenue and net income by fiscal year
| Fiscal year | Revenue | Net income |
|---|---|---|
| 2022 | 18.4B | 2.4B |
| 2023 | 20.5B | 3.2B |
| 2024 | 22.6B | 3.0B |
| 2025 | 25.1B | 3.2B |
Price context
Over the last year Stryker Corp traded between 270.01 and 385.39, most recently 281.87.
How the verdict is built
Four independent models run on every company: a discounted cash flow, a revenue-driven growth DCF for businesses reinvesting everything into growth, valuation multiples against sector peers, and Graham with a dividend-discount model. They are weighted by the kind of business rather than averaged flat, so a cash-burning grower and a utility are not treated alike.
Strike Optics is an analytics and research tool for education. Nothing here is investment advice.
Other companies
All companies · Valuation glossary · Open the free tier, no account needed.